Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Penile Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Fluorouracil 3Watchful Waiting 2Taxes 2Polymerase Chain Reaction 2Paclitaxel 2Light Coagulation 2Imiquimod 2Cisplatin 2Carboplatin 2cabozantinib 1Vorinostat 1Triage 1Specimen Handling 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Platinum 1Observation 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Isotretinoin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Histological Techniques 1Electrocoagulation 1Coal Tar 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Isotretinoin × Gynecologic × Clear all
NCT00001073 2021-11-04

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
150 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡